Akeila Bio
Ann Arbor, Michigan, United States
About Akeila Bio
Akeila Bio is a biotech start-up company developing breakthrough medicines that target the retinoid X receptor (RXR) to treat a broad range of diseases driven by dysregulation of the immune system, glucose metabolism, and lipid metabolism.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2023)
- Website: akeilabio.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/akeila-bio-2579990 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.